share_log

复星医药(02196.HK)4月29日举行董事会会议考虑及通过一季度业绩

Fosun Pharmaceutical (02196.HK) held a board meeting on April 29 to consider and approve the first quarter results

Gelonghui Finance ·  Apr 17 16:50

Gelonghui, April 17, 丨 Fosun Pharmaceutical (02196.HK) announced that it will hold a board meeting on April 29, 2024 (Monday) to consider, approve and publish the first quarter results of the company and its subsidiaries for the three months ended March 31, 2024.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment